SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-15-000367
Filing Date
2015-05-12
Accepted
2015-05-12 16:32:01
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR THE PERIOD ENDED 3/31/2015 appy_10q-033115.htm 10-Q 458125
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 12582
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 12556
4 EXHIBIT 32 ex32.htm EX-32 7678
  Complete submission text file 0001079973-15-000367.txt   5308931

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT appy-20150331.xml EX-101.INS 642721
6 XBRL TAXONOMY EXTENSION SCHEMA appy-20150331.xsd EX-101.SCH 38492
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appy-20150331_cal.xml EX-101.CAL 44604
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE appy-20150331_def.xml EX-101.DEF 221151
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE appy-20150331_lab.xml EX-101.LAB 789969
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appy-20150331_pre.xml EX-101.PRE 398039
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
Venaxis, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 15854831
SIC: 2835 In Vitro & In Vivo Diagnostic Substances